Sourcebio International Competitors and Similar CompaniesClear all

Sourcebio International's competitors and similar companies include Empress Therapeutics, MRIGlobal, MeMed Diagnostics and Igyxos.

	Sourcebio International Sourcebio International is a provider of laboratory products.	Empress Therapeutics Empress Therapeutics is a company that develops technology for drug discovery.	MRIGlobal MRIGlobal is a company that performs contract scientific and engineering research solutions.	MeMed Diagnostics MeMed Diagnostics is a med-tech and bio convergence company that provides diagnostic solutions.	Igyxos Igyxos is a biotech startup developing pharmaceuticals and medical technologies in the field of human fertility.
Founding Date	Founding Date 2016	Founding Date 2020	Founding Date 1943	Founding Date 2009	Founding Date 2019
Type	Type Public	Type Private	Type Private	Type Private	Type Private
Tags	Tags Technology drug development medical diagnostics	Tags Technology biotech drug development healthtech medical diagnostics platform	Tags Healthcare clinical research drug development energy services medical diagnostics	Tags Technology biotech drug development medical diagnostics medtech platform	Tags Healthcare Technology biotech drug development healthtech medical diagnostics pharma
Locations	Locations HQ	Locations Cambridge, US HQ	Locations Kansas City, US HQ Charlottesville, US Gaithersburg, US Golden, US North Kansas City, US Washington, US Arlington, US see more	Locations Tirat Carmel, IL HQ	Locations Nouzilly, FR HQ
Employees	Employees N/A	Employees 296% decrease	Employees 403	Employees 1081% decrease	Employees 15
Financial
Revenue (est.)	Revenue (est.) £92.4m (FY, 2021)	Revenue (est.) N/A	Revenue (est.) $902.3k (FY, 2023)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods £53.3m (FY, 2021)	Cost of goods N/A	Cost of goods $882.3k (FY, 2023)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit £39.3m (FY, 2021)	Gross profit N/A	Gross profit $20k (FY, 2023)	Gross profit N/A	Gross profit N/A
Net income	Net income £16.7m (FY, 2021)	Net income N/A	Net income $16.7k (FY, 2023)	Net income N/A	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 50m (almost 3 years ago)	Latest funding round N/A	Latest funding round $ 2.8m (over 6 years ago)	Latest funding round $ 8.5m (about 7 years ago)
Total funding raised	Total funding raised N/A	Total funding raised $ 50m	Total funding raised N/A	Total funding raised $ 79.9m	Total funding raised $ 8.5m